We are live on ! Find out more
NP

NS Partners Portfolio holdings

AUM $2.23B
1-Year Est. Return 20.03%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+20.03%
3 Year Est. Return
+81.73%
5 Year Est. Return
+107.4%
10 Year Est. Return
+450.74%
AUM
$555M
AUM Growth
-$4.64M
Cap. Flow
-$8.21M
Cap. Flow %
-1.48%
Top 10 Hldgs %
26.28%
Holding
123
New
15
Increased
63
Reduced
30
Closed
7

Sector Composition

1 Technology 16.14%
2 Healthcare 15.75%
3 Financials 15.51%
4 Industrials 12.86%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.9T
$27.4M 4.93%
1,004,688
+82,180
+9% +$2.05M
MSFT icon
2
Microsoft
MSFT
$2.93T
$16.8M 3.02%
304,045
+17,054
+6% +$894K
RYAAY icon
3
Ryanair
RYAAY
$32.5B
$15.2M 2.74%
442,953
-226,757
-34% -$7.48M
JPM icon
4
JPMorgan Chase
JPM
$907B
$14.3M 2.57%
240,687
+16,028
+7% +$936K
HON icon
5
Honeywell
HON
$71.3B
$12.8M 2.3%
127,030
+5,004
+4% +$469K
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.22T
$12.6M 2.27%
338,940
+10,960
+3% +$393K
PEP icon
7
PepsiCo
PEP
$187B
$12M 2.17%
117,327
+6,777
+6% +$670K
ORCL icon
8
Oracle
ORCL
$364B
$11.9M 2.14%
290,550
+155,514
+115% +$5.76M
CSCO icon
9
Cisco
CSCO
$441B
$11.6M 2.09%
408,351
-47,825
-10% -$1.23M
TJX icon
10
TJX Companies
TJX
$171B
$11.3M 2.04%
289,124
+44,414
+18% +$1.61M
CVS icon
11
CVS Health
CVS
$137B
$10.5M 1.89%
101,145
+8,402
+9% +$817K
XOM icon
12
ExxonMobil
XOM
$611B
$10.2M 1.84%
122,031
+41,814
+52% +$3.35M
PFE icon
13
Pfizer
PFE
$143B
$10.1M 1.82%
359,036
-53,680
-13% -$1.53M
BLK icon
14
Blackrock
BLK
$166B
$9.6M 1.73%
28,178
+704
+3% +$223K
MDT icon
15
Medtronic
MDT
$106B
$9.27M 1.67%
123,627
-21,127
-15% -$1.59M
EL icon
16
Estee Lauder
EL
$29.7B
$9.1M 1.64%
96,534
+13,022
+16% +$1.16M
LMT icon
17
Lockheed Martin
LMT
$117B
$8.95M 1.61%
40,417
-7,217
-15% -$1.55M
DIS icon
18
Walt Disney
DIS
$170B
$8.14M 1.47%
82,000
-3,913
-5% -$378K
WFC icon
19
Wells Fargo
WFC
$265B
$7.95M 1.43%
164,368
+23,460
+17% +$1.15M
C icon
20
Citigroup
C
$217B
$7.86M 1.42%
188,229
+9,340
+5% +$390K
AGN
21
DELISTED
Allergan plc
AGN
$7.74M 1.39%
28,862
+1,255
+5% +$359K
BMY icon
22
Bristol-Myers Squibb
BMY
$124B
$7.69M 1.38%
120,313
+7,632
+7% +$481K
SYK icon
23
Stryker
SYK
$123B
$7.62M 1.37%
71,042
+1,403
+2% +$138K
GE icon
24
GE Aerospace
GE
$364B
$7.45M 1.34%
+48,870
New +$6.9M
NOC icon
25
Northrop Grumman
NOC
$74.1B
$7.36M 1.33%
37,183
+648
+2% +$122K

Similar funds

NS Partners's Q1 2016 Portfolio in Review

As of Q1 2016, NS Partners held 123 positions worth $555M, down 0.83% from $560M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

NS Partners's Q1 2016 filing shows 15 new, 63 increased, 30 reduced and 7 closed positions. Its largest new stake was GE Aerospace: 48,870 shares worth $7.45M. The largest sale was Accenture, an estimated $7.54M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • NS Partners's largest Q1 2016 buy was GE Aerospace: 48,870 shares worth $7.45M.
  • NS Partners added most to Oracle in Q1 2016, an estimated $5.76M increase.
  • NS Partners's biggest Q1 2016 reduction was Accenture, cutting an estimated $7.54M.
  • NS Partners fully exited Vermilion Energy in Q1 2016, selling an estimated $3.6M.
  • NS Partners's ten largest holdings make up 26% of its $555M portfolio in Q1 2016.
  • NS Partners opened 15 new positions and closed 7 in Q1 2016.
  • NS Partners's portfolio value fell 0.83% quarter-over-quarter to $555M.

Based on NS Partners's 13F filing for Q1 2016, filed 13 May 2016.